{
  "docId": "019de511-96cd-7638-a1d6-3e4d5ad533a5",
  "docSlug": "302359bc76c31f98badc01a5486f3d4f",
  "documentTitle": "Thorne HealthTech | IPO Presentation Deck | 45 slides",
  "authorId": "thorne-healthtech",
  "authorName": "Thorne HealthTech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7910448,
  "pageNumber": 25,
  "pageCount": 45,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses product imagery to anchor the number of clinical trials associated with each specific supplement.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-96cd-7638-a1d6-3e4d5ad533a5/25",
  "deckHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5",
  "deckJsonHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5.json",
  "deckAnchorHref": "/decks/019de511-96cd-7638-a1d6-3e4d5ad533a5#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "image",
      "text": "Four product bottles with trial counts above them",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5cf92b97-28c4-44aa-8fe7-673ca12d7541",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.65
      },
      "kind": "list",
      "text": "New customer acquisition: Clinical research drives acquisition with health professionals.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b6f79f5-00b1-45f1-a012-73e34bd0921e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "list",
      "text": "Ongoing trials: We are currently participating in 23 ongoing trials.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea7f2d4e-ba89-44c3-9e4b-0cbb388f4100",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.55,
        "y": 0.45
      },
      "kind": "list",
      "text": "Clinical research enables us to: Validate safety/efficacy, expand indications, develop novel testing.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec209919-66df-41a2-b09a-eb29dc07ef6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "metric",
      "text": "35 trials, 8 trials, 2 trials, 2 trials",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7053598-f085-48ed-b075-d6e95ae4bdbb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Detailed footnotes regarding specific trial counts for Meriva 500-SF, Quercetin Phytosome, NiaCel 400, and Crucera-SGS.",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5bf215f9-b6a2-4a5d-8c01-42f3894cedff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Clinical Research Studies Support Brand and Partnerships",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c11c7cd-b1f9-4d07-a3b7-7aaadbf679c3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "02163abf-0461-4147-884a-0d9de4f5d4ff",
      "evidence": "The deck presents the cost of inaction implicitly throughout the narrative, with an explicit mention on slide 36.",
      "position": 0,
      "objective": "What is the cost of not transforming human health?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}